DiJoseph, J.; Khandke, K.; Dougher, M.; Evans, D.; Armellino, D.; Hamann, P.; Damle, N. CMC-544 (inotuzumab ozogamicin): A CD22-Targeted Immunoconjugate of Calicheamicin. Hematol Meeting Rep 2009, 2.